Edition:
United States

Merck & Co Inc (MRK.N)

MRK.N on New York Stock Exchange

82.38USD
1:49pm EDT
Change (% chg)

$1.17 (+1.44%)
Prev Close
$81.21
Open
$81.24
Day's High
$82.43
Day's Low
$80.89
Volume
906,948
Avg. Vol
3,398,965
52-wk High
$87.07
52-wk Low
$62.52

Select another date:

Wed, Jul 17 2019

Photo

Merck's treatment for urinary, abdominal infections gets FDA approval

The U.S. Food and Drug Administration has approved Merck & Co Inc's combination treatment for complicated forms of urinary tract and abdominal infections, the drugmaker said on Wednesday.

UPDATE 2-Merck's treatment for urinary, abdominal infections gets FDA approval

July 17 The U.S. Food and Drug Administration has approved Merck & Co Inc's combination treatment for complicated forms of urinary tract and abdominal infections, the drugmaker said on Wednesday.

Merck's treatment for urinary, abdominal infections gets FDA approval

July 17 The U.S. Food and Drug Administration has approved Merck & Co Inc's combination treatment for complicated forms of urinary tract and abdominal infections, the drugmaker said on Wednesday.

Appeals court mulls reviving Merck's $2.54 billion patent win against Gilead

A federal appeals court on Tuesday was considering whether to reinstate a $2.54 billion jury verdict Merck & Co Inc won against Gilead Sciences Inc in a dispute over hepatitis C treatments — the largest ever in a patent infringement case.

U.S. judge strikes down Trump administration rule requiring drug prices in TV ads

A federal judge on Monday dealt a blow to the Trump administration by striking down a new rule that would have forced pharmaceutical companies to include the wholesale prices of their drugs in television advertising.

Merck CEO sees legal challenge if U.S. adopts drug pricing based on other countries

NEW YORK Merck & Co Chief Executive Ken Frazier said on Thursday a rule to base the price the U.S. government pays for some prescription drugs in it Medicare program on lower prices in other countries would face legal challenges if adopted.

Merck CEO sees legal challenge if U.S. adopts drug pricing based on other countries

NEW YORK, June 20 Merck & Co Chief Executive Ken Frazier said on Thursday a rule to base the price the U.S. government pays for some prescription drugs in it Medicare program on lower prices in other countries would face legal challenges if adopted.

Walmart, Merck in blockchain collaboration with FDA

June 13 IBM Corp, Merck & Co, KPMG and Walmart Inc said on Thursday they will be a part of U.S. Food and Drug Administration's pilot program that will explore using blockchain to identify, track and trace prescription drugs.

Merck's Keytruda wins FDA approval to treat head and neck cancer

Merck & Co Inc said on Tuesday its blockbuster cancer drug Keytruda won approval from the U.S. Food and Drug Administration to treat a type of head and neck cancer.

UPDATE 1-Merck's Keytruda wins FDA approval to treat head and neck cancer

June 11 Merck & Co Inc said on Tuesday its blockbuster cancer drug Keytruda won approval from the U.S. Food and Drug Administration to treat a type of head and neck cancer.

Select another date: